Home › Leukemie › North Carolina › Durham
Leukemie klinische studies in Durham, NC
13 studies voor Leukemie zoeken deelnemers op locaties in en rond Durham (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
RekruterenFase 3
- Quetzal Site 27, Chapel Hill · 10 mijl verwijderd
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
RekruterenFase 1/2
- Duke University Medical Center, Durham
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
RekruterenFase 3
- Duke University Medical Center, Durham
- University of North Carolina, Chapel Hill, Chapel Hill · 10 mijl verwijderd
DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics
Rekruteren
- Lineberger Comphrehensive Cancer Center at University of North Carolina, Chapel Hill · 10 mijl verwijderd
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
RekruterenFase 1/2
- University of North Carolina at Chapel Hill/ University of North Carolina Medical Center, Chapel Hill · 10 mijl verwijderd
Strength Training Exercise in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (STEP-ALL)
RekruterenGezonde vrijwilligers welkom
- University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mijl verwijderd
Registry of Older Patients With Cancer
RekruterenObservatieonderzoek
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mijl verwijderd
A Study of Revumenib and Mezigdomide in People With Leukemia
RekruterenFase 1/2
- University of North Carolina (Data Collection Only), Chapel Hill · 10 mijl verwijderd
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
RekruterenFase 2/3
- Duke University, Durham
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
RekruterenFase 1
- Duke Blood Cancer Center, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruterenObservatieonderzoek
- Massive Bio SYNERGY-AI site, Chapel Hill · 10 mijl verwijderd
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
RekruterenObservatieonderzoek
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mijl verwijderd
A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
RekruterenFase 2
- Durham VA Medical Center, Durham, NC, Durham
Leukemie studies in andere steden
- Houston, TX28 studies
- Boston, MA25 studies
- New York City, NY19 studies
- Los Angeles, CA16 studies
- Chicago, IL16 studies
- Baldwin Park, CA12 studies
- Columbus, OH12 studies
- Nashville, TN12 studies
- Philadelphia, PA12 studies
- Milwaukee, WI11 studies
- Atlanta, GA11 studies
- Seattle, WA11 studies
Andere studies in Durham
- Borstkanker63 studies
- Kanker (alle vormen)58 studies
- Niet-kleincellige longkanker39 studies
- Multipel myeloom37 studies
- Metastatische kanker33 studies
- Acute myeloïde leukemie33 studies
- Longkanker32 studies
- Prostaatkanker32 studies
- Colorectale kanker28 studies
- Chronische lymfatische leukemie27 studies
- Eierstokkanker27 studies
- Hartfalen26 studies
Van ClinicalTrials.gov, gegevens opgehaald op 5 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.